Effectiveness of comprehensive supports for schizophrenic women during pregnancy and puerperium: Preliminary study

Psychiatry and Clinical Neurosciences

Volumn 61, Issue 6, 2007, Pages 665-671

  Nishizawa, Osamu ^a   Sakumoto, Kaoru ^a   Hiramatsu, Ken Ichi ^b   Kondo, Tsuyoshi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b Oasis Social Welfare Corporation   (Japan)

Author keywords

Child care; Pregnancy; Puerperium; Schizophrenia; Support

Indexed keywords

ANTIPARKINSON AGENT; BIPERIDEN; CHLORPROMAZINE; DIAZEPAM; HYPNOTIC SEDATIVE AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DELIVERY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MENTAL DETERIORATION; MENTAL DISEASE; MENTAL HEALTH; PATIENT MONITORING; POSITIVE AND NEGATIVE SYNDROME SCALE; PREGNANCY; PREGNANT WOMAN; PRESCRIPTION; PROSPECTIVE STUDY; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; PUERPERIUM; REMISSION; SCHIZOPHRENIA; SCORING SYSTEM;

ADULT; ANTIPSYCHOTIC AGENTS; CHILD; CHILD CARE; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTERS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SOCIAL SUPPORT;

EID: 36849083594     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2007.01721.x     Document Type: Article

References (27)

1. Howard LM, Kumar R, Thornicroft G. Psychosocial characteristics and needs of mothers with psychotic disorders. Br. J. Psychiatry 2001 178 : 427 432.
2. Howard LM, Goss C, Leese M, Appleby L, Thornicroft G. The psychosocial outcome of pregnancy in women with psychotic disorder. Schizophr. Res. 2004 71 : 49 60.
3. Trixler M, Gati A, Tenyi T. Risks associated with childbearing in schizophrenia. Acta Psychiatr. Belg. 1995 95 : 159 162 (Abstract).
4. Miller LJ, Finnerty M. Sexuality, pregnancy, and childrearing among women with schizophrenia-spectrum disorders. Psychiatr. Serv. 1996 47 : 502 506.
5. Miller LJ. Sexuality, reproduction, and family planning in women with schizophrenia. Schizophr. Bull. 1997 23 : 623 635.
6. Trixler M, Gati A, Fekete S, Tenyi T. Use of antipsychotics in the management of schizophrenia during pregnancy. Drugs 2005 65 : 1193 1206.
7. McKenna K, Koren G, Tetelbaum M et al. Pregnancy outcome of women using atypical antipsychotic drugs: A prospective comparative study. J. Clin. Psychiatry 2005 66 : 444 449.
8. Briggs GC, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 7th edn. Williams & Wilkins, Baltimore, MD, 2005.
9. American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 1994 93 : 137 150.
10. Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich LA. Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am. J. Psychiatry 2005 162 : 79 91.
11. Nilsson E, Lichtenstein P, Cnattingius S, Murray RM, Hultman CM. Women with schizophrenia: Pregnancy outcome and infant death among their offspring. Schizophr. Res. 2002 58 : 221 229.
12. Bennedsen BE, Mortensen PB, Olesen AV, Henriksen TB. Congenital malformations, stillbirths, and infant deaths among children of women with schizophrenia. Arch. Gen. Psychiatry 2001 58 : 674 679.
13. Abel KM, Webb RT, Salmon MP, Wan MW, Appleby L. Prevalence and predictors of parenting outcomes in a cohort of mothers with schizophrenia admitted for joint mother and baby psychiatric care in England. J. Clin. Psychiatry 2005 66 : 781 789.
14. Seeman MV, Cohen R. A service for women with schizophrenia. Psychiatr. Serv. 1998 49 : 674 677.
15. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. WHO, Geneva, 1993.
16. Stanley K, Lewis O, Abraham FM. Positive and Negative Syndrome Scale Rating Manual. Mukti-Health Systems, Toronto, 1991.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV). American Psychiatric Association, Washington, DC, 1994.
18. Inagaki A, Inada T. Dose equivalence of psychotropic drugs. Part XVIII: dose equivalence of psychotropic drugs. Part: 2006-version. Jpn J. Clin. Psychopharmacol. 2006 9 : 1443 1447 (in Japanese).
19. Okazaki Y, Honda Y. Support system to prevent relapse for female with psychiatric disease. Jpn J. Midwive 1985 39 : 776 778 (in Japanese).
20. Verdoux H, Geddes JR, Takei N et al. Obstetric complications and age at onset in schizophrenia: An international collaborative meta-analysis of individual patient data. Am. J. Psychiatry 1997 154 : 1220 1227.
21. Cannon M, Huttunen MO, Tanskanen A et al. Perinatal and childhood risk factors for later criminality and violence in schizophrenia. Br. J. Psychiatry 2002 180 : 496 501.
22. Byrne M, Browne R, Mulryan N et al. Labour and delivery complications and schizophrenia: Case-control study using contemporaneous labour ward records. Br. J. Psychiatry 2000 176 : 531 536.
23. Kendell RE, McInneny K, Juszczak E, Bain M. Obstetric complications and schizophrenia: Two-control studies based on structured obstetric records. Br. J. Psychiatry 2000 176 : 516 522.
24. Coverdale JH, McCullough LB, Chervenak FA. Assisted and surrogate decision making for pregnant patients who have schizophrenia. Schizophr. Bull. 2004 30 : 659 664.
25. McNeil TF, Cantor-Graae E, Ismail B. Obstetric complications and congenital malformation in schizophrenia. Brain Res. Brain Res. Rev. 2000 31 : 166 178.
26. Kunugi H, Nanko S, Murray RM. Obstetric complications and schizophrenia: Prenatal underdevelopment and subsequent neurodevelopmental impairment. Br. J. Psychiatry Suppl. 2001 40 : 25 29.
27. Rosso IM, Cannon TD, Huttunen T, Huttunen MO, Lonnqvist J, Gasperoni TL. Obstetric risk factors for early-onset schizophrenia in a Finnish birth cohort. Am. J. Psychiatry 2000 157 : 801 807.